Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2025-08-29 00:00:00 ET · period of report 2025-08-27 · accession 0001231615-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2025-08-29 | 2025-08-27+ | AXSM | JEFFS ROGER | Dir | S - Sale | $121.72 | -60.0K | 111.0K | -35% | -$7.30M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-29 | S | D | 20,000 | $121.27 | 70,974 | D | — | — | (F5) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.02 and $122.28. |
| 2 | Common | Common Stock | 2025-08-28 | S | D | 20,000 | $121.60 | 90,974 | D | — | — | (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.75 and $122.47. |
| 3 | Common | Common Stock | 2025-08-27 | S | D | 20,000 | $122.30 | 110,974 | D | — | — | (F3) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $120.74 and $123.56. |